XML 41 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The potential common shares in the following tables represent potential common shares from outstanding options, restricted stock awards, convertible notes and other convertible securities that were excluded from the calculation of diluted EPS during periods due to having an anti-dilutive effect are:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Average market price during the period

 

$

0.91

 

 

$

4.29

 

 

$

0.71

 

 

$

4.37

 

Option awards

 

 

2,159,574

 

 

 

1,529,824

 

 

 

2,159,574

 

 

 

1,000,722

 

Unvested restricted stock awards

 

 

 

 

 

10,087

 

 

 

 

 

 

 

SPA written call options

 

 

4,618,546

 

 

 

 

 

 

4,618,546

 

 

 

 

Convertible notes

 

 

18,858,952

 

 

 

341,776

 

 

 

18,858,952

 

 

 

147,134

 

Common Stock Warrant related

 

 

10,267,387

 

 

 

10,923,525

 

 

 

10,267,387

 

 

 

1,819,472

 

Put Options

 

 

 

 

 

3,871,880

 

 

 

3,871,880

 

 

 

 

Equity exchange rights in connection with Mexican Corporate Transactions

 

 

1,841,132

 

 

 

 

 

 

1,841,132

 

 

 

 

 

Reconciliation of Numerators and Denominators used in Computing Basic and Diluted Net Income Per Share

The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income per share:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to Odyssey Marine Exploration, Inc.

 

$

(14,847,963

)

 

$

(1,527,103

)

 

$

(12,606,393

)

 

$

1,970,921

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic net (loss) income available to stockholders

 

$

(14,847,963

)

 

$

(1,527,103

)

 

$

(12,606,393

)

 

$

1,970,921

 

Fair value change of debt instruments

 

 

 

 

 

 

 

 

 

 

 

(243,253

)

Fair value change of warrants

 

 

 

 

 

 

 

 

 

 

 

(682,667

)

Fair value change of convertible debt

 

 

 

 

 

 

 

 

 

 

 

(354,411

)

Diluted net (loss) income available to stockholders

 

$

(14,847,963

)

 

$

(1,527,103

)

 

$

(12,606,393

)

 

$

690,590

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – Basic

 

 

30,750,588

 

 

 

20,481,072

 

 

 

29,931,163

 

 

 

20,453,503

 

Dilutive effect of options

 

 

 

 

 

 

 

 

 

 

 

69,816

 

Dilutive effect of other derivative instruments

 

 

 

 

 

 

 

 

 

 

 

3,871,880

 

Dilutive effect of warrants

 

 

 

 

 

 

 

 

 

 

 

1,777,412

 

Dilutive effect of convertible debt instruments

 

 

 

 

 

 

 

 

 

 

 

189,502

 

Weighted average common shares outstanding – Diluted

 

 

30,750,588

 

 

 

20,481,072

 

 

 

29,931,163

 

 

 

26,362,113

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.48

)

 

$

(0.07

)

 

$

(0.42

)

 

$

0.10

 

Diluted

 

$

(0.48

)

 

$

(0.07

)

 

$

(0.42

)

 

$

0.03